Solution Study: Dr. Carsten Schauerte, Managing Director of solid-chem GmbH
When it comes to property data quality, Reaxys meets the needs for effective analytics, saving time and advancing scientific work
Time is a precious commodity for Dr. Carsten Schauerte, managing director of the chemicals company solid-chem GmbH. Searching for high-quality answers was one of the most time-consuming tasks for him and his team until he started using Reaxys. Thanks to its smarter chemistry search capabilities, he can accomplish more in less time.
The scientists at solid-chem use a broad spectrum of analytical techniques to examine chemical samples from customers. This involves gathering all the relevant, experimentally determined information about the properties of the substances. Finding this information is essential to knowing the optimal techniques to apply in order to deliver impactful answers efficiently. This generally involves searching multiple databases and high volumes of literature and patents, which makes it a complex, time-consuming process.
"I have found Reaxys to have an amount and diversity of substance properties unlike any other tool I’ve used." Dr. Carsten Schauerte, solid-chem GmbH
According to Dr. Schauerte, Reaxys saves time because it simplifies the overall search for answers. He believes it can help them standardize and streamline their search workflow, making it easier to find properties and the optimal methods for their experiments. Since the data has proven to be high quality and well linked to the literature, they can directly use it. This translates to shorter delivery times and lower costs for their customers. Reaxys helps him and his team accomplish more.
"I’m impressed with the linking from Reaxys to sources, especially to patent content because navigating the different patent systems can be very time-consuming." Dr. Carsten Schauerte, solid-chem GmbH
Download the free case study to learn more
Elsevier R&D Solutions supporting solid-chem GmbH
Enable better informed preclinical drug safety decisions with comprehensive, fully searchable FDA/EMA drug approval documents and comparative extracted drug safety data.
Learn more about PharmaPendium